Back to 
UBS Group AG
UBS Group AG
XTLB1 quarters
Position history for UBS Group AG's holdings in XTL BIOPHARMACEUTICALS LTD
UBS Group AG holds 125 shares of XTLB (XTL BIOPHARMACEUTICALS LTD), worth $341 as of 2026-Q2. This is a new position.
Current Value
$341
Current Shares
125
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of XTLB: RHUMBLINE ADVISERS, MORGAN STANLEY